Enantio- and Chemo-Selective HPLC Analysis of Silodosin on an Amylose-Based Chiral Stationary Phase
Molecules · 2025
DOI: 10.3390/molecules30091966 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Daniele Sadutto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for the Control and Evaluation of Medicines, Chemical Medicines Unit, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy. Hauptthemen laut MEDLINE: Amylose, Indoles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A direct enantio- and chemo-selective high-performance liquid chromatographic method was developed for determining the enantiomeric impurity of the chiral active pharmaceutical ingredient silodosin. The simultaneous separation of enantiomers of silodosin and its main organic related substances listed in the Japanese Pharmacopoeia (JP) monograph for drug substance was achieved on Chiralpak AD-3 (250 mm × 4.6 mm, 3 μm) column under normal-phase isocratic conditions. The optimized conditions employed the mixture n-heptane-ethanol-diethylamine (70:30:0.1) (v/v/v) as a mobile phase and a temperature of 35 °C. The complete separation of the enantiomers of silodosin and its main impurities was obtained within 12 min. The chromatographic method has been validated according to the International Conference on Harmonization (ICH) guidelines and compared with the method reported in the JP monograph. The standard curve for silodosin exhibited linearity (R2 > 0.999) within the concentration range of 1.13–2500 µg mL−1. The Chiralpak AD-3 has demonstrated a remarkable level of efficiency, enabling the attainment of limits of quantitation for silodosin of 1.13 µg mL−1 (equivalent to 0.057% of a sample solution of 2 mg mL−1) and ranging from 0.48 µg mL−1 to 1.94 µg mL−1 for other impurities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for the Control and Evaluation of Medicines, Chemical Medicines Unit, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
ORCID-Profile: Daniele Sadutto, Francesca Romana Mammone, Roberto Cirilli
Zitieren
APA
Sadutto, D., Mammone, F. R., D'Ettorre, G., Zanitti, L., De Orsi, D., Alfonsi, R., Prestinaci, F., & Cirilli, R. (2025). Enantio- and Chemo-Selective HPLC Analysis of Silodosin on an Amylose-Based Chiral Stationary Phase. Molecules. https://doi.org/10.3390/molecules30091966
Vancouver
Sadutto D, Mammone FR, D'Ettorre G, Zanitti L, De Orsi D, Alfonsi R, et al. Enantio- and Chemo-Selective HPLC Analysis of Silodosin on an Amylose-Based Chiral Stationary Phase. Molecules. 2025. doi:10.3390/molecules30091966
BibTeX
@article{Sadutto2025,
author = {Sadutto, Daniele and Mammone, Francesca Romana and D'Ettorre, Giulia and Zanitti, Leo and De Orsi, Daniela and Alfonsi, Romina and Prestinaci, Francesca and Cirilli, Roberto},
title = {Enantio- and Chemo-Selective HPLC Analysis of Silodosin on an Amylose-Based Chiral Stationary Phase},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30091966}
}
EUVIMED